EXICURE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
EXICURE, INC. (XCUR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $0 as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2025-03-18
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-06-17 |
| 2023-12-31 | $0.00 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 10-Q · filed 2024-05-16 |
| 2023-06-30 | $0.00 10-Q/A · filed 2024-06-06 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-25 |
| 2021-09-30 | $396.00K 10-Q · filed 2021-11-19 |
| 2021-06-30 | $1.01M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.70M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.68M 10-K · filed 2021-03-11 |
| 2020-09-30 | $2.09M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.61M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.46M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.62M 10-K · filed 2020-03-10 |
| 2019-09-30 | $3.75M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.52M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.23M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $7.29M 10-K/A · filed 2019-09-23 |
| 2018-09-30 | $9.42M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $16.73M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $5.19M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $5.18M 10-K · filed 2018-03-09 |
| 2017-09-30 | $5.20M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |